Articles & Video
eBook: Diversity, Equity and Inclusion in Biotech & Pharma
Analysis and insights on championing diversity, equity and inclusion from leading biotech and pharmaceutical executives and investors.
REPORT: Diversity, Equity and Inclusion in the Life Sciences 2021
Explore the Diversity, Equity and Inclusion in the Life Sciences 2021 report based on an exclusive study of 483 industry professionals.
Life Sciences Survey: COVID-19 Impacts One Year On
Take part in our industry survey on the impacts of COVID-19 on the life sciences one year on to get exclusive early access to the final report.
SURVEY: Diversity, Equity and Inclusion in the Life Sciences 2021
Complete our survey on Diversity, Equity and Inclusion in the Life Sciences 2021 to get exclusive early access to the final report.
Diversity in leadership and boards: a checklist for biotech companies
We review key considerations for biotech companies to ensure diverse representation in leadership and boards.
Increasing diversity in clinical trials for COVID-19 vaccines and beyond
What has the COVID-19 pandemic taught us about how to achieve diversity in clinical trials?
5 ways that venture capital investors can drive diversity in biotech
What responsibilities do investors have to increase diversity in the biotech sector? We look at key strategies discussed at BioPharm America Digital.
REPORT: The Future of Healthcare Post COVID-19
In our latest report learn how healthcare organizations are adapting to succeed post COVID-19, from innovation to product development.
Women in Pharma: 44% of pharma professionals think that women are under represented in their organization
44% of pharma professionals think that women are under represented in their organization according to new data from an Informa Connect Life Sciences study. Here we deep dive into the data.
Diversity and Inclusion in Biotech
The life science industry has a challenge to become more equal, diverse and inclusive. Join us at Diversity and Inclusion in Biotech, September 22nd and find out how TOGETHER we can make a difference.
SURVEY: Partnering and Deal-Making in Biopharma through the Pandemic
We are conducting a huge study to gauge perspectives around biopharma deal-making during COVID-19 and the commercial ramifications of the pandemic. Take part here.
Diversity in the life sciences workplace: Implementing a leading corporate culture for innovation - WHITEPAPER
This paper looks at how to foster racial, gender, geographical, neuro and cognitive diversity in the life sciences to achieve an inclusive culture built for innovation.
REPORT: Diversity, Inclusion and Sustainability in the Global Life Sciences Industry 2020
Diversity and Inclusion in Life Sciences 2020: Research analysis of how life sciences professionals around the world view representation of women and minorities in the industry, plus the importance of sustainability.
Diversity and Inclusion: 6 best practices for biotech and pharma companies
MassBio's Edie Stringfellow presents 6 ways biotech and pharma companies are improving their working cultures with diversity and inclusion initiatives.
Strategies and case studies on diversity from leading life sciences organizations - WHITEPAPER
Diversity in life sciences - This whitepaper looks at case studies of organizations who have successfully developed tools and practices to enhance diversity.
Diversity and inclusion offer visibility for the underrepresented in Life Sciences
Edie Stringfellow, Mass Bio's first ever Director of Diversity and Inclusion, and VisionSpring co-founder Erica Colonero explore the importance of diversity and inclusion.
3M VP talks remaining innovative and embracing diversity
Yolla Levitt, VP at 3M, explores how collaboration, cross-pollination and diversity are all key to innovation in this exclusive interview.
While diversity is the acceptance of differences inclusion leverages those differences
Karen Albertson, Global Business Director at 3M SPSD, shares her thoughts on the importance of diversity and inclusion in the biotech industry.
"Achieving diversity and inclusion requires engagement from all of us" - Dr. Joan Reede
We spoke with Dr. Joan Reede, Dean for Diversity and Community Partnership at Harvard Medical School on the need to keep having conversations around diversity and inclusion to enforce the changes we want to see.